Korro Bio, Inc. Deferred Federal, State and Local, Tax Expense (Benefit)
Korro Bio, Inc. (KRRO) reported Deferred Federal, State and Local, Tax Expense (Benefit) of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit · last filed 2023-11-02
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for the quarter ending 2023-09-30 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for the quarter ending 2023-06-30 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for the quarter ending 2023-03-31 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for the quarter ending 2022-12-31 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2021 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2020 was $0.00.
- Korro Bio, Inc. deferred federal, state and local, tax expense (benefit) for fiscal 2019 was $0.00.
| Period end | Deferred Federal, State and Local, Tax Expense (Benefit) 3 month | Deferred Federal, State and Local, Tax Expense (Benefit) 6 month | Deferred Federal, State and Local, Tax Expense (Benefit) 9 month | Deferred Federal, State and Local, Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-11-02 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 derived: sum of 3 quarters · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 derived: sum of 3 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-03-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-10 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | $0.00 derived: sum of 3 quarters · filed 2023-03-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $0.00 derived: sum of 2 quarters · filed 2023-03-10 | $0.00 derived: sum of 3 quarters · filed 2023-03-10 | $0.00 10-K · filed 2023-03-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-18 | |||
| 2018-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |